Kafatos G; Niepel D; Lowe K; Jenkins-Anderson S; Westhead H; Tímár, József; Tóth, Erika
(2017)
AIM: A confirmed wild-type RAS tumor status is commonly required for prescribing anti-EGFR treatment for metastatic colorectal cancer. This noninterventional, observational research project estimated RAS mutation prevalence ...